DePuy Orthopaedics, Inc. 2022-02-16 Health serious FDA
Health · FDA · Recall #FDA-Z-0631-2022
ATTUNE REVISION POSTERIOR FEMORAL AUGMENT SZ 9 12MM-intended as a Component in total… Recall
Issued February 16, 2022 · DePuy Orthopaedics, Inc.
In February 2022, DePuy Orthopaedics, Inc. recalled the ATTUNE REVISION POSTERIOR FEMORAL AUGMENT SZ 9 12MM-intended as a Component in total…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur.
What you should do
- 1 Stop using ATTUNE REVISION POSTERIOR FEMORAL AUGMENT SZ 9 12MM-intended as a Component in total… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact DePuy Orthopaedics, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- DePuy Orthopaedics, Inc.
- Category
- Health
- Recall date
- February 16, 2022
- Units affected
- Not reported
- Sold at
- US Nationwide distribution in the states of TN, TX.
- Recall number
- FDA-Z-0631-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- DePuy Orthopaedics, Inc. has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.